REG - ConvaTec Group PLC - Scrip Dividend – Calculation Price

ConvaTecAnnouncement

07/04/2022 15:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220407:nRSG6906Ha&default-theme=true

RNS Number : 6906H  ConvaTec Group PLC  07 April 2022

Scrip Dividend - calculation price

 

 

Reading, United Kingdom (7 April 2022)

On 7 March 2022, the Board of Directors of ConvaTec Group Plc ("ConvaTec" or
"the Company") proposed a final dividend of 4.154 cents per share ("Final
Dividend"), subject to approval at the forthcoming Annual General Meeting on
12 May 2022. This Final Dividend is to be paid on 19 May 2022 to shareholders
on the share register as of 1 April 2022 ("Record Date"). The Final Dividend
is payable in cash, in sterling to holders of ordinary shares. The chosen
exchange rate for this payment is $1.314/£1.00, determined on 7 March 2022,
giving a total sterling dividend of £63,680,650. A scrip dividend will be
made available for this Final Dividend, allowing shareholders to elect to
receive their dividend in the form of new ordinary shares.

The "Calculation Price" for the issue of new ordinary shares under the scrip
dividend scheme is:

215.24 pence for each new ordinary share.

This is equivalent to 1 new share for approximately 68.09 shares held prior to
the ex-dividend date of 31 March 2022.

The Calculation Price is the average of the middle market quotations of a
ConvaTec share, derived from the London Stock Exchange Daily Official List,
for the five consecutive business days from 31 March to 6 April 2022
(inclusive).

The latest date for receipt of elections to participate in the scrip dividend
scheme for the Final Dividend is 27 April 2022. Shareholders must return their
mandate form by 5pm (BST) or otherwise input their CREST elections to be
received by the Company's registrar, Computershare, by 3pm (BST) on 27 April
2022. Elections received after this deadline will apply to subsequent
dividends only. Unless revoked by you, your scrip dividend election will apply
for all future dividends for which a scrip dividend is offered. Evergreen
elections for CREST shareholders cannot be accepted and elections will revert
to cash by default after the payment of each dividend.

Details of the scrip dividend scheme are available
at www.convatecgroup.com/investors (http://www.convatecgroup.com/investors) .

TIMETABLE

Key dates in respect of the scrip dividend scheme for the Final Dividend are:

 Ex-dividend Date                                                     31 March 2022
 Record Date                                                       1 April 2022
 Scrip calculation price determined                                31 March - 6 April 2022 (inclusive)
 Scrip calculation price available and announced                                                7 April 2022
 Mandate delivery deadline for Shares held in uncertificated form   3.00 p.m. on 27 April 2022
 Mandate delivery deadline for Shares held in certificated form    5.00 p.m. on 27 April 2022
 Announcement of the total amount of new shares to be issued                                            4 May 2022
 Dividend payment date                                                                                19 May
                                                                   2022
 Dispatch of statement in accordance with section 7 of Scheme                                         19 May
                                                                   2022

Rules and share certificates, CREST accounts credited/updated,

and first day of dealings in New Shares

 
 

 

 

Enquiries

Analysts and Investors

Kate Postans, VP Investor Relations

& Corporate Communications
 
             +44 (0)782 644 7807

ir@convatec.com (mailto:ir@convatec.com)

 

Media

Buchanan: Charles Ryland / Chris Lane
                                   +44 (0)207
466 5000
 
 

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

 

About ConvaTec

ConvaTec is a global medical products and technologies company focused on
therapies for the management of chronic conditions, with leading market
positions in advanced wound care, ostomy care, continence and critical care,
and infusion care. Our products provide a range of clinical and economic
benefits including infection prevention, protection of at-risk skin, improved
patient outcomes and reduced total cost of care. To learn more about ConvaTec,
please visit www.convatecgroup.com (http://www.convatecgroup.com/) .

 

 

# # #

END

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DIVBKOBQNBKDQQK